Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.41
Delayed Data
As of Dec 02
 +0.01 / +0.71%
Today’s Change
1.30
Today|||52-Week Range
2.35
-25.79%
Year-to-Date
The Worst Marijuana Stocks in 2016
Dec 02 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.40
Today’s open1.40
Day’s range1.37 - 1.46
Volume2,936,708
Average volume (3 months)1,532,550
Market cap$343.1M
Dividend yield--
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)-60.71%
Earnings growth (this year)+24.56%
Earnings growth (next 5 years)-45.30%
Revenue growth (last year)+3.67%
P/E ratioNM
Price/Sales11.93
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
CEMPCempra Inc+1.00+15.27%
SVASinovac Biotech Ltd-0.01-0.16%
SPPISpectrum Pharmaceuti...-0.10-2.44%
FOMXFoamix Pharmaceutica...+0.20+2.22%
Data as of 12/02/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$38.3M
Annual profit (last year)-$108.0M
Net profit margin-281.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Amit D. Munshi
SVP-Operations &
Head-Global Regulatory Affairs
Craig M. Audet
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs